We developed arid validated a coordinated set of RLs for the following eight sterokis in single small aliquots (1 mL) of plasma: androstenedione, 
tracted and then chromatographed on celite microcolumns. Radioiodinated tracers were used for two of the assays (17-Hpreg and 21-DF). Thtiated tracers and scintillation proximity assay counting were used to grve separation-free procedures for the other sb assays, which considerably improved their practicability and reproducibility. The basal and postadrenocorticotropichormone plasma values for these steroids in normalwomen sampled inthe follicular phase are presented. Finally, the measurementof the eight steroids as a diagnostic method is evaluated with reference to data from 203 patients withhirsutism and (or) acne. before and after stimulation with synthetic corticotropin (ACTH)- as well as results on the application of the method to the diagnosis of the origin of excess androgen production in patients with hirsutism and (or) acne. 
Materials and Methods

Reagents
Results Specificity
Cross-reactions were estimated according to Abraham's method (20) . Although there were no extraction or purifications steps, the operating conditions for the specificity assays were similar to those used routinely and the results are shown in Table 1 
Precision.
Overall, intraassay variations were between 4.3% and 7.2% (n = 13), whereas interassay variations were between 4.4% and 9.6% (n = 20) for the eight steroids studied ( Table 2) . Table 3 .
Samples from the same 20 healthy women were also analyzed for a wide variety of other hormones and endocrine-related substances.
Some mean ± SD concentra- 18, 21, 22) . These increased concentrations of 17-HP and 21-DF alone allowed diagnoses of 21-hydroxylase deficiency in these patients. The other six steroids were also high in many patients; 11-HA in particular was high in 9 of the 10 patients.
3. Patients (n = 7) with a concentration of 11-DF after synthetic ACTH-(1-24) administration consistently greater than the upper limit of 7.11 nmol/L (Table 4) . Apart from a small number already allocated to group 2 who had a very mild increase, this characteristic was not found in any other patients. These patients all exhibited very high concentrations of free urinary cortisol (250-1988 moI/L) and were diagnosed as having Cushing syndrome.
In these patients the spread of concentrations for the other steroids measured is very large.
Patients
(n = 18 + 3) whose consistent plasma steroid abnormality was a high basal concentration of androstenedione (A >7.10 nmoIjL), combined with normal 11-HA and DHEA (Table 4) . Included was one patient with increased basal and stimulated 21-DF concentrations, corresponding perhaps to a heterozygote form of 21-hydroxylase deficiency (18) (19) (20) (21) (22) (23) . Three patients had increased 17-HP, but this was not considered to be informative.
Nine had increased testosterone; this was just above normal in six patients (2.07-3.46 nmoll L), but in three patients it was much higher (5.19, 6.75,   and 12.80 nmolJL) , and was combined with very high concentrations of A (>15.70 nmoIJL) and normal 11-HA and DHEA. This pattern indicated the possibility of an ovarian tumor, and this diagnosis was confirmed in all three women by echography and ovarian and adrenal venous catheterization.
The other 18 patients were diagnosed as having a hyperandrogeny of ovarian origin (25) and the ranges reported in Table 4 apply only to them. They were further investigated with measurements of LH after GnRH administration.
They had the highest incidences of major menstrual irregularities (55%) and ovarian ultrasonography anomalies (72%) of any group, supporting the above diagnoses. Patients were classified into six groups on the basis of mean ± 2 SD upper (diagnostic)limits (sea Table 3 ). Significant, compared with controls, at b P <0.05, P <0.01," P <0.001. It is very effective for the diagnosis of 21-hydroxylase deficiency and, like the other more prolonged methods, suggests rather than proves the origin of the excess androgens. In addition, it allows the elimination of both ovarian and adrenal sources, as in idiopathic hirsutism
(patients of group 1).
This method has also shown us that some or all of the excess androgen production is of adrenal origin in 118 (groups 2, 5, and 6, or 58%) of the 203 patients. Therefore, for these patients, in addition to the anti-androgens generally used for the treatment of hirsutism and acne (37), treatment with glucocorticoids will often prevent the menstrual irregularities very often associated with hirsutism and acne (32, 33) and will facilitate pregnancy when it is desired.
Thorough clinical evaluation (hirsutism grade, degree of menstrual anomalies, ovarian echographic evaluation) is an essential preliminary and adjunct to hormonal evaluation.
To further confirm the diagnosis of patients presenting with hirsutism and (or) acne, we have also used the GnRH stimulation test, and we are presently investigating the results of measurements of 5a-androstane-3p,1713-diol glucuronide markers of the activity of cutaneous 5a-reductase, to further characterize the origin of idiopathic hirsutism.
